L(+)-Amethopterin hydrate structure
|
Common Name | L(+)-Amethopterin hydrate | ||
---|---|---|---|---|
CAS Number | 133073-73-1 | Molecular Weight | 454.43900 | |
Density | 1.536g/cm3 | Boiling Point | N/A | |
Molecular Formula | C20H22N8O5 | Melting Point | 195ºC | |
MSDS | Chinese USA | Flash Point | N/A | |
Symbol |
GHS06, GHS08 |
Signal Word | Danger |
Use of L(+)-Amethopterin hydrateMethotrexate (hydrate) is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
Name | L(+)-Amethopterin hydrate |
---|---|
Synonym | More Synonyms |
Description | Methotrexate (hydrate) is a biochemical reagent that can be used as a biological material or organic compound for life science related research. |
---|---|
Related Catalog |
Density | 1.536g/cm3 |
---|---|
Melting Point | 195ºC |
Molecular Formula | C20H22N8O5 |
Molecular Weight | 454.43900 |
Exact Mass | 454.17100 |
PSA | 210.54000 |
LogP | 1.82170 |
Vapour Pressure | 0mmHg at 25°C |
Symbol |
GHS06, GHS08 |
---|---|
Signal Word | Danger |
Hazard Statements | H301-H315-H319-H360 |
Precautionary Statements | P201-P301 + P310-P305 + P351 + P338-P308 + P313 |
Personal Protective Equipment | Eyeshields;Faceshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
Hazard Codes | T |
Risk Phrases | 61-25-36/38 |
Safety Phrases | S26-S45-S53-S36-S37 |
RIDADR | UN 2811 6.1/PG 3 |
WGK Germany | 3 |
RTECS | MA1225000 |
Retinoic acid synergizes ATO-mediated cytotoxicity by precluding Nrf2 activity in AML cells.
Br. J. Cancer 111(5) , 874-82, (2014) Standard therapy for acute promyelocytic leukaemia (APL) includes retinoic acid (all-trans retinoic acid (ATRA)), which promotes differentiation of promyelocytic blasts. Although co-administration of ... |
|
Cleavage efficient 2A peptides for high level monoclonal antibody expression in CHO cells.
MAbs 7(2) , 403-12, (2015) Linking the heavy chain (HC) and light chain (LC) genes required for monoclonal antibodies (mAb) production on a single cassette using 2A peptides allows control of LC and HC ratio and reduces non-exp... |
|
TLR signaling modulates side effects of anticancer therapy in the small intestine.
J. Immunol. 194(4) , 1983-95, (2015) Intestinal mucositis represents the most common complication of intensive chemotherapy, which has a severe adverse impact on quality of life of cancer patients. However, the precise pathophysiology re... |
MFCD00150848 |
L-Amethopterin hydrate |
Methotrexate Hydrate |